Turning 35 is not a medical cliff edge, but it is a meaningful checkpoint. From this age onward, the risk of chronic disease begins to rise more noticeably, even in people who feel fit, train regularly, and eat well. Cardiovascular disease, type 2 diabetes, and chronic inflammatory conditions often develop silently for years before symptoms appear.
Blood tests are one of the few tools that can detect these changes early, while there is still time to reverse course.
This article focuses on three blood tests that are strongly supported by scientific evidence and widely used in preventive medicine. They are not trendy biohacking markers or obscure lab values. They are tests that help identify real risk, guide lifestyle changes, and, when necessary, inform medical treatment.
The goal here is not fear, but clarity. Understanding what these tests measure, why they matter after 35, and how to interpret them can help you make better long-term decisions about training, nutrition, recovery, and overall health.
Why Blood Tests Matter More After 35
Aging does not happen overnight, but physiological changes do begin to accumulate more quickly in your mid-30s. Insulin sensitivity tends to decline, vascular stiffness slowly increases, and low-grade inflammation becomes more common. These shifts are subtle, but they set the stage for major health problems later in life.
Large population studies consistently show that markers such as cholesterol levels, blood glucose, and inflammatory proteins begin to diverge more sharply between healthy and unhealthy individuals after the age of 35. Importantly, many people with early-stage metabolic or cardiovascular dysfunction feel completely normal.
Blood tests allow you to see beneath the surface. They provide objective data that can reveal risk long before symptoms appear. This is especially relevant for physically active people, who may assume that regular training alone is enough to protect them. While exercise is powerful, it does not make anyone immune to poor lipid profiles, insulin resistance, or chronic inflammation.
Test 1: Lipid Profile (With a Focus on ApoB)
What This Test Measures
A standard lipid profile measures total cholesterol, low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides. These values have been used for decades to assess cardiovascular risk.
However, growing evidence shows that apolipoprotein B (ApoB) is a more accurate marker of risk than LDL cholesterol alone. ApoB represents the number of atherogenic lipoprotein particles in the blood. Each LDL, very-low-density lipoprotein (VLDL), and intermediate-density lipoprotein (IDL) particle contains one ApoB molecule.
More ApoB means more particles capable of penetrating the arterial wall and contributing to plaque formation.
Why It Matters After 35
Cardiovascular disease remains the leading cause of death worldwide. Atherosclerosis, the underlying process, often begins in early adulthood and progresses silently for decades. By the time symptoms such as chest pain appear, significant arterial damage has often already occurred.
Studies using imaging techniques have shown that plaque burden correlates more strongly with ApoB levels than with LDL cholesterol concentration. This is particularly important for people who have “normal” LDL-C but elevated particle numbers, a pattern that becomes more common with age, insulin resistance, and higher body fat.
After 35, cumulative exposure to atherogenic particles becomes a key driver of future risk. Measuring ApoB provides a clearer picture of that exposure.
What the Science Says
Multiple large-scale studies and meta-analyses have demonstrated that ApoB is a superior predictor of cardiovascular events compared to LDL-C or non-HDL cholesterol. Genetic studies also support a causal role for ApoB-containing particles in atherosclerosis.
Research published in major cardiology journals has shown that for a given LDL-C level, individuals with higher ApoB have significantly higher rates of heart attack and stroke. This finding holds true across different populations, sexes, and age groups.
How Lifestyle Affects Lipid Markers
Dietary patterns high in refined carbohydrates and ultra-processed foods tend to increase triglycerides and ApoB levels, even in people who exercise regularly. Excess visceral fat also drives higher production of ApoB-containing particles by the liver.
On the other hand, diets emphasizing whole foods, adequate protein, fiber, and unsaturated fats are associated with lower ApoB levels. Regular aerobic exercise and resistance training both improve lipid metabolism, though exercise alone may not normalize ApoB in everyone.
Sleep quality, stress, and alcohol intake also play meaningful roles. Chronic sleep restriction and high alcohol consumption are both linked to adverse lipid changes.
Interpreting Results
While reference ranges vary by laboratory, many experts consider an ApoB level below 90 mg/dL to be desirable for primary prevention, with lower targets recommended for higher-risk individuals. Importantly, optimal levels may differ depending on family history and other risk factors.
A single test is useful, but trends over time are more informative. Repeating measurements after lifestyle changes can help assess whether interventions are working.
Test 2: HbA1c (Long-Term Blood Sugar Control)
What This Test Measures
Hemoglobin A1c (HbA1c) reflects average blood glucose levels over the previous two to three months. It measures the percentage of hemoglobin molecules in red blood cells that have glucose attached to them.
Unlike fasting glucose, which captures a single moment in time, HbA1c provides a longer-term view of blood sugar control. This makes it particularly valuable for detecting early metabolic dysfunction.
Why It Matters After 35
Insulin sensitivity typically declines with age, even in physically active individuals. Muscle mass loss, reduced mitochondrial function, and hormonal changes all contribute to this shift. As a result, blood glucose regulation can worsen gradually without obvious symptoms.
Prediabetes is common after 35 and often goes undiagnosed. Many people with HbA1c values in the prediabetic range feel healthy and energetic, yet already have an increased risk of cardiovascular disease, cognitive decline, and progression to type 2 diabetes.
Early identification allows for lifestyle interventions that are far more effective before full-blown diabetes develops.
What the Science Says
Long-term cohort studies have shown a continuous relationship between HbA1c levels and risk of cardiovascular disease, even below the diagnostic threshold for diabetes. Each incremental increase in HbA1c is associated with higher rates of heart attack, stroke, and all-cause mortality.
Randomized controlled trials demonstrate that lifestyle interventions, particularly those involving weight loss, dietary changes, and increased physical activity, can significantly lower HbA1c and reduce progression from prediabetes to diabetes.
Importantly, resistance training and increased muscle mass have been shown to improve glucose disposal independently of weight loss.
How Training and Diet Influence HbA1c
High-intensity interval training, endurance exercise, and strength training all improve insulin sensitivity, but consistency matters more than intensity alone. Long periods of inactivity can negate many of the benefits of structured workouts.
Dietary patterns that emphasize minimally processed carbohydrates, adequate fiber, and sufficient protein are associated with better glycemic control. Excessive intake of sugar-sweetened beverages and refined grains has the opposite effect.
Sleep deprivation and chronic stress increase insulin resistance through hormonal mechanisms involving cortisol and sympathetic nervous system activation.
Interpreting Results
An HbA1c below 5.7 percent is generally considered normal, 5.7 to 6.4 percent indicates prediabetes, and 6.5 percent or higher is diagnostic of diabetes. However, risk increases continuously across this spectrum.
For physically active adults over 35, even values in the upper-normal range may warrant attention, particularly if there is a family history of diabetes or cardiovascular disease.
As with lipid markers, trends over time are crucial. Small improvements in HbA1c can translate into meaningful reductions in long-term risk.
Test 3: High-Sensitivity C-Reactive Protein (hs-CRP)
What This Test Measures
C-reactive protein (CRP) is produced by the liver in response to inflammation. The high-sensitivity version of the test (hs-CRP) can detect low-grade chronic inflammation that is not apparent with standard CRP assays.
Chronic low-grade inflammation is now recognized as a key driver of many age-related diseases, including atherosclerosis, type 2 diabetes, and neurodegenerative conditions.
Why It Matters After 35
As people age, baseline inflammation tends to increase, a phenomenon sometimes referred to as “inflammaging.” This process is influenced by body composition, physical activity, diet, sleep, and environmental factors.
Elevated hs-CRP levels are associated with higher risk of heart attack, stroke, and cardiovascular mortality, independent of cholesterol levels. This means someone with an apparently healthy lipid profile can still be at increased risk if chronic inflammation is present.
After 35, identifying and addressing sources of inflammation can have significant long-term benefits.
What the Science Says
Large prospective studies have consistently shown that hs-CRP predicts cardiovascular events in both men and women. In some studies, hs-CRP was as strong a predictor of risk as LDL cholesterol.
Clinical trials have demonstrated that interventions which reduce inflammation, including certain medications and lifestyle changes, are associated with lower cardiovascular event rates. Importantly, reductions in hs-CRP often predict improved outcomes even when cholesterol levels remain unchanged.
Inflammation also plays a role in insulin resistance and muscle recovery, making hs-CRP relevant for athletes and active individuals.
Lifestyle Factors That Influence Inflammation
Excess visceral fat is a major source of inflammatory cytokines. Weight loss, particularly reduction in abdominal fat, is strongly associated with lower hs-CRP levels.
Regular physical activity generally reduces baseline inflammation, though excessive training without adequate recovery can temporarily increase inflammatory markers.
Dietary patterns rich in fruits, vegetables, whole grains, and omega-3 fatty acids are associated with lower hs-CRP, while diets high in trans fats and refined carbohydrates are associated with higher levels.
Sleep quality and psychological stress also have measurable effects on inflammatory markers.
Interpreting Results
An hs-CRP level below 1.0 mg/L is considered low risk, 1.0 to 3.0 mg/L moderate risk, and above 3.0 mg/L high risk for cardiovascular events. Values above 10 mg/L usually indicate acute infection or injury and should be rechecked after recovery.
Because hs-CRP can fluctuate, it is best measured when you are healthy and not recovering from illness or intense training. Repeated measurements can help distinguish chronic inflammation from temporary spikes.
How These Three Tests Work Together
Each of these tests provides valuable information on its own, but their real strength lies in combination. Cardiovascular disease and metabolic dysfunction are multifactorial. Lipids reflect particle exposure, HbA1c reflects glucose regulation, and hs-CRP reflects inflammatory burden.
Someone with mildly elevated ApoB, borderline HbA1c, and moderate hs-CRP may appear “normal” on paper, yet already be on a trajectory toward future disease. Conversely, improvements across all three markers strongly suggest that lifestyle interventions are working.
This integrated approach aligns with modern preventive medicine, which focuses on overall risk rather than isolated numbers.
Common Misconceptions About Blood Tests
One common misconception is that normal results mean no risk. In reality, reference ranges are based on population averages, not optimal health. Many people develop disease despite values that were once considered acceptable.
Another misconception is that exercise alone guarantees good results. While physical activity is essential, it cannot always overcome poor diet, chronic stress, or genetic predisposition.
Finally, some people avoid testing out of fear of bad news. In practice, early information almost always expands options rather than limiting them.
How Often Should You Test?
For generally healthy adults over 35, testing these markers every one to three years is reasonable, depending on baseline results and risk factors. People with abnormal values or strong family histories may benefit from more frequent monitoring.
Testing should always be interpreted in context, ideally with a qualified healthcare professional who understands both the science and your individual circumstances.
The Bottom Line
Blood tests are not about chasing perfection or obsessing over numbers. They are tools for understanding risk, guiding action, and tracking progress over time.
For adults over 35, a lipid profile with ApoB, HbA1c, and hs-CRP provides a powerful snapshot of cardiovascular and metabolic health. These tests are well-studied, widely available, and actionable.
Used wisely, they can help you train smarter, eat better, recover more effectively, and protect your health for decades to come.
References
- Ference, B.A. et al. (2017) ‘Low-density lipoproteins cause atherosclerotic cardiovascular disease’, European Heart Journal, 38(32), pp. 2459–2472.
- Sniderman, A.D. et al. (2019) ‘Apolipoprotein B particles and cardiovascular disease’, Journal of the American College of Cardiology, 73(24), pp. 3236–3247.
- Emerging Risk Factors Collaboration (2010) ‘Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease’, The Lancet, 375(9733), pp. 2215–2222.
- Selvin, E. et al. (2010) ‘Glycated hemoglobin, diabetes, and cardiovascular risk’, New England Journal of Medicine, 362(9), pp. 800–811.
- Knowler, W.C. et al. (2002) ‘Reduction in the incidence of type 2 diabetes with lifestyle intervention’, New England Journal of Medicine, 346(6), pp. 393–403.
- Ridker, P.M. et al. (2000) ‘C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease’, New England Journal of Medicine, 342(12), pp. 836–843.
